Advertisement

Topics

Munich Leukemia Laboratory Selects IBM Watson and Illumina for Research Collaboration to Improve Diagnostics and Develop Personalized Treatment Tools for Leukemia & Lymphoma

02:00 EST 8 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Watson Takes on Hematology Research in First Collaboration in Germany; Effort Marks Illumina’s First European Adopter of NovaSeq™ Munich Leukemia Laboratory (MLL), a state-of-the-art leukemia and lymphoma diagnostic and ...

Other Sources for this Article

MLL Media Contact
Torsten Haferlach, +49 89 990170
torsten.haferlach@mll.com
or
IBM Media Contacts
IBM DACH
Annette Fassnacht, +49 151 65136642
annettefassnacht@de.ibm.com
or
IBM Watson Health
Christine Douglass
cgdouglass@us.ibm.com
or
Illumina, Inc. Contacts
Investors:
Rebecca Chambers, 858-255-5243
ir@illumina.com
or
Media:
David Robertson, +44 1223 824909
(Europe, Middle East, and Africa)
or
Jen Carroll, 858-882-6822
(US)
pr@illumina.com

NEXT ARTICLE

More From BioPortfolio on "Munich Leukemia Laboratory Selects IBM Watson and Illumina for Research Collaboration to Improve Diagnostics and Develop Personalized Treatment Tools for Leukemia & Lymphoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...